The reason it was introduced weekly was there was less side effects, less neuropathy but same benefits. It may finish 3weeks earlier as in last visit to hospital but it's still in your system.
Taxol is taxotere. Docetaxol is a different drug. Both in the same class but different risjs. The conversation you need to have about docetaxol with your oncologist us about risks.
My understanding with the taxane based treatments is that docetaxol is the only one that risks permanent hair loss or reduced hair growth after treatment. It is a small % but a very real risk and devastating for the individual. Do have the discussion about this and know the risks before basing a decision just on schedule length. I'm not trying to frighten you but feel its important you are given all the information about the difference with the 2 drugs before making your final decision.
Kath x